| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.6M | -30.1% | +333.5% |
| Cost of Revenue | $3.9M | -23.7% | +418.0% |
| Gross Profit | $773K | -51.0% | +138.5% |
| R&D Expense | $59K | +3.3% | +38.9% |
| SG&A Expense | $5.1M | +114.0% | +313.7% |
| Operating Income | -$4.5M | -424.0% | -372.7% |
| Net Income | -$5.5M | -345.5% | -470.3% |
| EPS (Basic) | -$0.16 | -300.0% | -433.3% |
| EPS (Diluted) | -$0.16 | -300.0% | -433.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $242K | -72.8% | -26.3% |
| Accounts Receivable | $5.3M | +1.9% | +220.6% |
| Inventory | $1.9M | +25.5% | -8.7% |
| Current Assets | $7.8M | -6.9% | +93.7% |
| Total Assets | $10.1M | +19.7% | +151.7% |
| Current Liabilities | $3.7M | -34.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | -83.6% | — |
| Investing Cash Flow | -$500K | — | — |
| Financing Cash Flow | $4.5M | +74.8% | — |
| +1009.2% |
| Total Liabilities | $5.1M | -19.1% | +612.0% |
| Stockholders' Equity | $5.0M | +134.5% | +51.6% |